ZimVie Inc. (ZIMV)
| Market Cap | 602.97M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 26.08M |
| EPS (ttm) | -4.66 |
| PE Ratio | n/a |
| Forward PE | 11.03 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 240,034 |
| Open | 22.71 |
| Previous Close | 23.02 |
| Day's Range | 22.25 - 23.55 |
| 52-Week Range | 18.83 - 50.40 |
| Beta | n/a |
| Analysts | Sell |
| Price Target | n/a |
| Earnings Date | May 5, 2022 |
About ZIMV
ZimVie Inc., a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-sp...
Financial Performance
In 2021, ZimVie's revenue was $1.01 billion, an increase of 11.20% compared to the previous year's $912.40 million. Losses were -$95.30 million, -46.79% less than in 2020.
Financial StatementsNews
ZimVie Reports First Quarter 2022 Financial Results
WESTMINSTER, Colo., May 05, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today reported financial results for the quarter ended Mar...
ZimVie to Report First Quarter 2022 Financial Results on May 5, 2022
WESTMINSTER, Colo., April 12, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the first...
ZimVie Reports 2021 Financial Results, Reaffirms 2022 Financial Guidance, and Provides Supplemental Financial Informa...
WESTMINSTER, Colo., March 31, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today reported financial results for the three months an...
ZimVie Completes Separation from Zimmer Biomet; Announces Board of Directors
WESTMINSTER, Colo., March 01, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV) today announced its debut as an independent publicly traded company and the completion of its separation from Zimmer Bio...